The Collision Of 340B Pricing And Medicare Drug Price Negotiation Rory MartinandKatheryne Richardson July 31, 2026

https://www.healthaffairs.org/content/forefront/collision-340b-pricing-and-medicare-drug-price-negotiation?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-8oXXeko6f_Dr2Ne_7MDNL6ehMj9cMJDDnENSy6Rj9q7PO8pAsz-hZVU29t2gYeY_4Xwfr3npOzTIXEJT5Iy_8W9yFF1Q&_hsmi=431087348&utm_source=hasu When the first set of prices under the Medicare Drug Price Negotiation Program went into effect, they intersected with the 340B Drug Pricing Program and created the potential for billions of dollars in duplicate discounts and administrative complexity.